搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
TheHealthSite
7 天
Dealing With Atopic Dermatitis In Winter: Cause, Symptoms, Treatment, Prevention
Winter season can trigger symptoms of atopic dermatitis by causing the skin to become dry and itchy in the cold weather. It ...
2 天
Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical ...
Data continue to demonstrate a favorable safety and efficacy profile, including improvements in IGA 0 or 1 and EASI 75 scores ...
조선일보
1 天
Shaperon secures phase 2 trials for atopic dermatitis treatment Nugel after positive review
Shaperon secures phase 2 trials for atopic dermatitis treatment Nugel after positive review Shaperon obtains approval for ...
Healio
1 天
Topical JAK, TYK inhibitor shows efficacy in phase 2a trial for atopic dermatitis
Technoderma Medicines has completed its phase 2a trial of TDM-180935 for the treatment of atopic dermatitis, demonstrating ...
Verywell Health on MSN
10 天
Dermatitis Types and Treatment Options
Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...
9 小时
JP Morgan 2025: Almirall updates strategy with focus on medical dermatology
Spain's Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit growth within the dermatological area for Almirall's psoriasis and atopic ...
dermatologyadvisor
1 天
In Atopic Dermatitis, Dupilumab Use Linked to Less Sleep, Psychiatric Disorders
Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.
Too Old to Operate
5 小时
Biomarker Profiles in CHE With and Without AD
The following is a summary of “Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients ...
조선일보
1 天
Shaperon stock rises 16% following successful phase 2b trial for atopic treatment
Shaperon successfully completed part 1 of the multinational phase 2 clinical trial of 'HY209 gel' targeting patients with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈